BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33604385)

  • 1. Upregulation of Versican Associated with Tumor Progression, Metastasis, and Poor Prognosis in Bladder Carcinoma.
    Zhang Q; Wu J; Chen X; Zhao M; Zhang D; Gao F
    Biomed Res Int; 2021; 2021():6949864. PubMed ID: 33604385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma.
    Mitsui Y; Shiina H; Kato T; Maekawa S; Hashimoto Y; Shiina M; Imai-Sumida M; Kulkarni P; Dasgupta P; Wong RK; Hiraki M; Arichi N; Fukuhara S; Yamamura S; Majid S; Saini S; Deng G; Dahiya R; Nakajima K; Tanaka Y
    Mol Cancer Res; 2017 Jul; 15(7):884-895. PubMed ID: 28242813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed versican promoted cell multiplication, migration and invasion in gastric cancer.
    Zhai L; Chen W; Cui B; Yu B; Wang Y; Liu H
    Tissue Cell; 2021 Dec; 73():101611. PubMed ID: 34358918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression level of BLCA-4 correlates with poor prognosis in human bladder cancer.
    Zhao Q; Shen WH; Chen ZW; Zhou ZS; Ji HX
    Int J Clin Exp Pathol; 2012; 5(5):422-7. PubMed ID: 22808294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z; Tu L; Chen M; Tong S
    BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma.
    Luo HL; Chang YL; Liu HY; Wu YT; Sung MT; Su YL; Huang CC; Wang PC; Peng JM
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of versican and its role in pancreatic neuroendocrine tumors.
    Gao H; Cheng Y; Chen Y; Luo F; Shao Y; Sun Z; Bai C
    Pancreatology; 2020 Jan; 20(1):142-147. PubMed ID: 31771905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.
    Said N; Sanchez-Carbayo M; Smith SC; Theodorescu D
    J Clin Invest; 2012 Apr; 122(4):1503-18. PubMed ID: 22406535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.
    Salem M; O'Brien JA; Bernaudo S; Shawer H; Ye G; Brkić J; Amleh A; Vanderhyden BC; Refky B; Yang BB; Krylov SN; Peng C
    Cancer Res; 2018 Aug; 78(15):4175-4190. PubMed ID: 29748371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
    Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C
    Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
    Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
    Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
    Chen F; Wang Q; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.
    Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY
    Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Sluiter NR; de Cuba EM; Kwakman R; Meijerink WJ; Delis-van Diemen PM; Coupé VM; Beliën JA; Meijer GA; de Hingh IH; te Velde EA
    Clin Exp Metastasis; 2016 Apr; 33(4):297-307. PubMed ID: 26873137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblasts and the related Runt-related transcription factor 2 (RUNX2) promote bladder cancer progression.
    Liu B; Pan S; Liu J; Kong C
    Gene; 2021 Apr; 775():145451. PubMed ID: 33482279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients.
    Ning XH; Qi YY; Wang FX; Li SC; Jia ZK; Yang JJ
    Biomed Res Int; 2020; 2020():7272960. PubMed ID: 33150179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
    Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
    BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update.
    He RQ; Huang ZG; Li TY; Wei YP; Chen G; Lin XG; Wang QY
    Cell Physiol Biochem; 2018; 50(4):1474-1495. PubMed ID: 30359990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Versican A-subdomain is required for its adequate function in dermal development.
    Hatano S; Nagai N; Sugiura N; Tsuchimoto J; Isogai Z; Kimata K; Ota A; Karnan S; Hosokawa Y; Watanabe H
    Connect Tissue Res; 2018 Mar; 59(2):178-190. PubMed ID: 28488903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of stromal versican expression in advanced stage serous ovarian cancer.
    Ghosh S; Albitar L; LeBaron R; Welch WR; Samimi G; Birrer MJ; Berkowitz RS; Mok SC
    Gynecol Oncol; 2010 Oct; 119(1):114-20. PubMed ID: 20619446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.